Browsing Tag
Yale School of Public Health
2 posts
60 Degrees Pharmaceuticals eyes FDA approval pathway for tafenoquine in babesiosis treatment
60 Degrees Pharmaceuticals targets FDA approval for tafenoquine in babesiosis as January 2027 trial results approach. Explore the risks.
Could this malaria drug become a breakthrough babesiosis cure? Yale and 60 Degrees aim to find out
Find out how 60 Degrees Pharmaceuticals and Yale are working to develop tafenoquine as a treatment for babesiosis, a rising tick-borne disease threat.